DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
QuantumLeap Healthcare Collaborative
QuantumLeap Healthcare Collaborative
Olema Pharmaceuticals, Inc.
University of Pittsburgh
Merck Sharp & Dohme LLC
Eli Lilly and Company
NRG Oncology
Eli Lilly and Company
Novartis
Hoosier Cancer Research Network
University of Washington
University of Virginia
SAPU NANO (US) LLC
Fudan University
Merck Sharp & Dohme LLC